AstraZeneca · 19 hours ago
Biologics Engineering: Cell Therapy R&D Summer Intern
US - Gaithersburg - MD
Internship
Onsite
Intern
$39/hr - $41.50/hrAstraZeneca is seeking undergraduate senior and Master's level students for a 12-week internship role in Gaithersburg, MD. The role focuses on supporting research and development in cell therapy, requiring wet lab skills and a background in relevant biological disciplines.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
No H1B
Qualification
Required
Undergraduate senior and Master's level students majoring in Biology, Immunology, Biochemistry, Chemistry or a related discipline. Candidates must have an expected graduation date after August 2026
Wet lab skills, such as primary cell culture, tumor cell culture, pipetting, etc. are required
Experience with basic molecular biology, such as PCR, gel electrophoresis, cloning/assembly, bacterial transformation, plasmid prep are required
Experience with cell culture work, including but not limited to mammalian and primary cell lines and overall aseptic techniques are required
Ability to report onsite to Gaithersburg, MD 5 days per week; this position may occasionally require onsite weekend hours. This role will not provide relocation assistance
US Work Authorization is required at time of application
This role will not be providing CPT support
Preferred
Experience with lentivirus transduction, tittering, co-culture, and flow cytometry, cell counting, and luciferase-based readouts are preferred
Experience with software including but not limited to FloJo, Megalign Pro, SeqBuilder Pro, Prism are preferred
Experience with cytotoxicity assays, such as MSD and flow cytometry are preferred
Ability to collaborate and work together in a team, stay organized, and problem-solving are preferred
Experience with software such as FloJo, Prism, Microsoft are preferred
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
Founded in 1999
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Leadership Team
Pascal Soriot
Executive Director and Chief Executive Officer
Aradhana Sarin
Group CFO and Executive Director
Recent News
Pharma Letter
2026-01-22
Clinical Trials Arena
2026-01-22
2026-01-22
Company data provided by crunchbase